Clinical Trial Update: Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating galantamine (Reminyl) for Alzheimer's disease using diffusion tensor MRI to assess treatment effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Reminyl (galantamine)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Alzheimer's Disease | Phase 4 | Status: UNKNOWN